Enveric BiosciencesENVB
13F holders, Q4 2025 (December 31)11holders
$3.63avg. 13F price*
At the end of Q4 2025, 11 institutions reported holding Enveric Biosciences Inc. (ENVB) in their 13F filings. The largest holders were AdvisorShares Investments LLC ($62K), UBS Group AG ($11K) and Citigroup Inc. ($8K).
- Company
- Enveric Biosciences Inc.
- CUSIP
- 29405E505
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $8K |
| Exits | 0 | $0 |
Ownership 11 holders
| AdvisorShares Investments LLC | 0.01% | Reduce -56.7% | 16,974 | $62K |
| UBS Group AG | 0.00% | Reduce -85.7% | 2,895 | $11K |
| Citigroup Inc. | 0.00% | New | 2,276 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +312.3% | 1,917 | $7K |
| BlackRock, Inc. | 0.00% | Reduce -55.9% | 51 | $185 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -57.5% | 49 | $178 |
| Bank of America Corp. | 0.00% | No change | 5 | $18 |
| Wells Fargo & Company | 0.00% | Add +160.0% | 1 | $4 |
| Danske Bank A/S | 0.00% | New | 1 | $4 |
| National Bank of Canada | 0.00% | Add +4.0% | 1 | $4 |
| Group One Trading LLC | 0.00% | Add +420.0% | 1 | $4 |
"% of holder's portfolio" is ENVB's weight in each manager's 13F, not the share of Enveric Biosciences Inc. the manager owns.